Biosynex SA (ENXTPA:ALBIO) signed a binding offer to acquire AVALUN SAS on April 7, 2021. The legal documentation for the transaction is expected to be finalized by the end of April. Biosynex SA (ENXTPA:ALBIO) completed the acquisition of AVALUN SAS on April 30, 2021. Under the terms of consideration, acquisition was paid for a majority share in cash and a minority share in BIOSYNEX shares.